Earlier this year, leading UK pharmaceutical trade outlet The Pharma Letter published an OpEd from Amicus Therapeutics’ Executive Chairman John Crowley and General Manager for the UK and Ireland Charlie Galvin, who wrote on the industry’s obligation to ensure the value created through innovation is shared with both patients and health systems alike.
This OpEd is based on a speech delivered by Charlie to the UK’s Royal Pharmaceutical Society in May 2022, introducing the BSP and its mission, as well as the industry’s responsibility to ensure the value of innovation is recognized across health systems as a whole.
Read the whole article at The Pharma Letter.